Ledermann, JA;
(2019)
Extending the scope of PARP inhibitors in ovarian cancer.
[Editorial comment].
The Lancet Oncology
, 20
(4)
pp. 470-472.
10.1016/S1470-2045(19)30019-1.
Preview |
Text
Ledermann_Extending the scope of PARP inhibitors in ovarian cancer_AAM.pdf - Accepted Version Download (483kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Extending the scope of PARP inhibitors in ovarian cancer |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S1470-2045(19)30019-1 |
| Publisher version: | https://doi.org/10.1016/S1470-2045(19)30019-1 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10074278 |
Downloads since deposit
177Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
